- One-pot biosynthesis of 1,6-hexanediol from cyclohexane by: De novo designed cascade biocatalysis
-
1,6-Hexanediol (HDO) is an important precursor in the polymer industry. The current industrial route to produce HDO involves energy intensive and hazardous multistage (four-pot-four-step) chemical reactions using cyclohexane (CH) as the starting material, which leads to serious environmental problems. Here, we report the development of a biocatalytic cascade process for the biotransformation of CH to HDO under mild conditions in a one-pot-one-step manner. This cascade biocatalysis operates by using a microbial consortium composed of three E. coli cell modules, each containing the necessary enzymes. The cell modules with assigned functions were engineered in parallel, followed by combination to construct E. coli consortia for use in biotransformations. The engineered E. coli consortia, which contained the corresponding cell modules, efficiently converted not only CH or cyclohexanol to HDO, but also other cycloalkanes or cycloalkanols to related dihydric alcohols. In conclusion, the newly developed biocatalytic process provides a promising alternative to the current industrial process for manufacturing HDO and related dihydric alcohols. This journal is
- Kang, Lixin,Li, Aitao,Li, Qian,Li, Renjie,Wang, Fei,Yu, Xiaojuan,Zhang, Zhongwei,Zhao, Jing
-
p. 7476 - 7483
(2020/11/23)
-
- Hydrogenation of dicarboxylic acids to diols over Re-Pd catalysts
-
A Re-Pd/SiO2 (Re/Pd = 8) catalyst was applied to hydrogenation of dicarboxylic acids (succinic acid, glutaric acid and adipic acid) to diols. In the hydrogenation of dicarboxylic acids, ex situ liquid-phase (in only 1,4-dioxane solvent) reduced Re-Pd/SiO2 showed much higher activity than in situ liquid-phase (in the mixture of dicarboxylic acid and 1,4-dioxane) and gas-phase reduced ones, in which the in situ liquid-phase reduced catalyst has been reported to show good activity in the hydrogenation of monocarboxylic acids. High diol yields (71-89%) were achieved in the hydrogenation of dicarboxylic acids on the ex situ liquid-phase reduced catalyst at 413 K. Lactones and hydroxycarboxylic acids were first formed as intermediates in the reaction of C4-C5 and ≥C6 dicarboxylic acids, respectively. Characterization using XRD, XPS and XAS indicates that ex situ liquid-phase reduced catalysts with high activity contains comparable amounts of Re0 and Ren+ species, both of which have been reported to be necessary for good performance. The amount of Ren+ species on the in situ liquid-phase reduced catalysts is much larger than that of surface Re0 species. This result suggests that the presence of dicarboxylic acids suppresses the reduction of Re species to Re0 on the calcined catalysts while that of monocarboxylic acids does not, which leads to the low activity in the hydrogenation of dicarboxylic acids on in situ liquid-phase reduced catalysts.
- Takeda, Yasuyuki,Tamura, Masazumi,Nakagawa, Yoshinao,Okumura, Kazu,Tomishige, Keiichi
-
p. 5668 - 5683
(2016/07/21)
-
- Bioreversible derivatives of phenol. 2. Reactivity of carbonate esters with fatty acid-like structures towards hydrolysis in aqueous solutions
-
A series of model phenol carbonate ester prodrugs encompassing derivatives with fatty acid-like structures were synthesized and their stability as a function of pH (range 0.4-12.5) at 37°C in aqueous buffer solutions investigated. The hydrolysis rates in aqueous solutions differed widely, depending on the selected pro-moieties (alkyl and aryl substituents). The observed reactivity differences could be rationalized by the inductive and steric properties of the substituent groups when taking into account that the mechanism of hydrolysis may change when the type of pro-moiety is altered, e.g. n-alkyl vs. t-butyl. Hydrolysis of the phenolic carbonate ester 2-(phenoxycarbonyloxy)-acetic acid was increased due to intramolecular catalysis, as compared to the derivatives synthesized from ω-hydroxy carboxylic acids with longer alkyl chains. The carbonate esters appear to be less reactive towards specific acid and base catalyzed hydrolysis than phenyl acetate. The results underline that it is unrealistic to expect that phenolic carbonate ester prodrugs can be utilized in ready to use aqueous formulations. The stability of the carbonate ester derivatives with fatty acid-like structures, expected to interact with the plasma protein human serum albumin, proved sufficient for further in vitro and in vivo evaluation of the potential of utilizing HSA binding in combination with the prodrug approach for optimization of drug pharmacokinetics.
- stergaard, Jesper,Larsen, Claus
-
p. 2396 - 2412
(2008/02/14)
-